Dianbao Zhang

877 total citations
54 papers, 636 citations indexed

About

Dianbao Zhang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Dianbao Zhang has authored 54 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 14 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Dianbao Zhang's work include RNA Interference and Gene Delivery (7 papers), MicroRNA in disease regulation (7 papers) and Mesenchymal stem cell research (6 papers). Dianbao Zhang is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), MicroRNA in disease regulation (7 papers) and Mesenchymal stem cell research (6 papers). Dianbao Zhang collaborates with scholars based in China, Saudi Arabia and United Kingdom. Dianbao Zhang's co-authors include Lili Jin, Xining Pang, Hongchuan Xin, Jiayu Chen, Qiuyu Wang, Rui Wang, Ping Shi, Feng Zhao, Zhe Wang and Zixiang Wang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Dianbao Zhang

51 papers receiving 627 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Dianbao Zhang 323 117 77 71 66 54 636
Amina Khadjavi 214 0.7× 78 0.7× 94 1.2× 119 1.7× 73 1.1× 35 683
Ran Xie 373 1.2× 118 1.0× 84 1.1× 96 1.4× 19 0.3× 19 826
Tessa M. Simone 305 0.9× 86 0.7× 100 1.3× 79 1.1× 36 0.5× 20 608
Razieh Dalirfardouei 367 1.1× 113 1.0× 54 0.7× 35 0.5× 124 1.9× 17 558
Hanwen Li 326 1.0× 61 0.5× 50 0.6× 111 1.6× 18 0.3× 54 799
Silke Durka 311 1.0× 65 0.6× 17 0.2× 33 0.5× 60 0.9× 12 597
Bin Feng 413 1.3× 185 1.6× 81 1.1× 75 1.1× 9 0.1× 47 779
Ludovic Micallef 209 0.6× 46 0.4× 66 0.9× 46 0.6× 184 2.8× 12 694
Takuya Iyoda 215 0.7× 84 0.7× 61 0.8× 24 0.3× 61 0.9× 37 540

Countries citing papers authored by Dianbao Zhang

Since Specialization
Citations

This map shows the geographic impact of Dianbao Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dianbao Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dianbao Zhang more than expected).

Fields of papers citing papers by Dianbao Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dianbao Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dianbao Zhang. The network helps show where Dianbao Zhang may publish in the future.

Co-authorship network of co-authors of Dianbao Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Dianbao Zhang. A scholar is included among the top collaborators of Dianbao Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dianbao Zhang. Dianbao Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Tingting, et al.. (2025). Antimicrobial Peptides for Skin Wound Healing. Biomolecules. 15(11). 1613–1613.
2.
Qian, He, Dianbao Zhang, Min Gao, et al.. (2025). Hydrophobicity causes anomalous migration of cystine/glutamate antiporter SLC7A11 in SDSPAGE with low acrylamide concentration. FEBS Open Bio. 15(6). 994–1008. 1 indexed citations
3.
Yang, Lan, et al.. (2025). The Effects of Counter-Ions on Peptide Structure, Activity, and Applications. Biomolecules. 15(11). 1567–1567.
4.
Zhang, Dianbao, et al.. (2024). Immune checkpoint inhibitor retreatment in second-line treatment of esophageal cancer: A real-world study.. Journal of Clinical Oncology. 42(16_suppl). e16034–e16034.
5.
Li, Yuying, et al.. (2023). Therapeutic Peptides for Treatment of Lung Diseases: Infection, Fibrosis, and Cancer. International Journal of Molecular Sciences. 24(10). 8642–8642. 8 indexed citations
6.
Liu, Ying, et al.. (2023). Fibroblast Growth Factors for Nonalcoholic Fatty Liver Disease: Opportunities and Challenges. International Journal of Molecular Sciences. 24(5). 4583–4583. 21 indexed citations
7.
Jin, Lili, et al.. (2023). REST Is Not Resting: REST/NRSF in Health and Disease. Biomolecules. 13(10). 1477–1477. 13 indexed citations
8.
Zhang, Dianbao, et al.. (2023). Dysregulated expression of microRNA involved in resistance to osimertinib in EGFR mutant non-small cell lung cancer cells. Journal of Thoracic Disease. 15(4). 1978–1993. 7 indexed citations
9.
Zhang, Dianbao, Yixuan Wang, Chen Pan, et al.. (2023). A new prognostic model of esophageal squamous cell carcinoma based on Cloud-least squares support vector machine. Journal of Thoracic Disease. 15(9). 4938–4948. 1 indexed citations
10.
Sun, Ji, Dianbao Zhang, & Yiling Li. (2022). Extracellular Vesicles in Pathogenesis and Treatment of Metabolic Associated Fatty Liver Disease. Frontiers in Physiology. 13. 909518–909518. 8 indexed citations
11.
Jin, Lili, Yuying Li, Hanyu Zhang, et al.. (2021). A synthetic peptide AWRK6 ameliorates metabolic associated fatty liver disease: involvement of lipid and glucose homeostasis. Peptides. 143. 170597–170597. 12 indexed citations
12.
Zhao, Feng, Zhe Wang, Tao Zhang, et al.. (2019). Human Novel MicroRNA Seq-915_x4024 in Keratinocytes Contributes to Skin Regeneration by Suppressing Scar Formation. Molecular Therapy — Nucleic Acids. 14. 410–423. 17 indexed citations
13.
Xu, Haipeng, et al.. (2019). <p>Conformance Assessment of PD-L1 Expression Between Primary Tumour and Nodal Metastases in Non-Small-Cell Lung Cancer</p>. OncoTargets and Therapy. Volume 12. 11541–11547. 14 indexed citations
14.
Wang, Qiuyu, Chunlin Zhao, Lili Jin, et al.. (2018). AWRK6, a Novel GLP-1 Receptor Agonist, Attenuates Diabetes by Stimulating Insulin Secretion. International Journal of Molecular Sciences. 19(10). 3053–3053. 8 indexed citations
15.
Zhang, Tao, Xiaohang Li, Dianbao Zhang, et al.. (2017). Repression of COUP-TFI Improves Bone Marrow-Derived Mesenchymal Stem Cell Differentiation into Insulin-Producing Cells. Molecular Therapy — Nucleic Acids. 8. 220–231. 5 indexed citations
16.
Zhang, Dianbao & Jun Yao. (2016). Efficacy of CIK combined with interventional embolism chemotherapy in hepatocellular carcinoma for stage III. Central Plains Medical Journal. 43(12). 10–11. 1 indexed citations
19.
Wang, Xiliang, Tao Zhang, Jing Wang, et al.. (2015). miR-378b Promotes Differentiation of Keratinocytes through NKX3.1. PLoS ONE. 10(8). e0136049–e0136049. 29 indexed citations
20.
Wang, Zhe, Dianbao Zhang, Xiaoyu Liu, et al.. (2015). Effect of advanced glycosylation end products on apoptosis in human adipose tissue-derived stem cells in vitro. Cell & Bioscience. 5(1). 3–3. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026